Amrize Ltd (AMRZ)

Current Report Filed: 2026-04-29

Key Insights

Amrize Ltd announced Q1 2026 financial results on April 29, 2026, with detailed financial information provided in the press release (Exhibit 99.1), though specific revenue, earnings, or guidance figures are not disclosed in the 8-K itself.
The company has prepared supplementary investor materials including a presentation available on their investor relations website, suggesting management is actively communicating with investors beyond standard SEC disclosures.
The 8-K was signed by CFO Baris Oran on the same day as the earnings announcement, indicating timely and proper filing compliance with SEC requirements for current material events.

Insider Trading Filed: 2026-04-22

Key Insights

Director Gibson Dwight Audley Konrad executed a net acquisition of 3,716 ordinary shares (740 shares sold at $57.12, followed by 2,976 shares acquired at $0) on 04/21/2026, bringing his total beneficial ownership to 5,194 shares.
The $0 acquisition price for 2,976 shares indicates this was a restricted stock unit (RSU) vesting event under the 2025 Omnibus Incentive Plan, vesting on the earlier of the one-year anniversary or next annual shareholder meeting, reflecting standard director compensation.
The director's sale of 740 shares at $57.12 prior to RSU vesting suggests potential portfolio rebalancing or tax management rather than loss of confidence, as the net position increased substantially with the RSU vesting.

Insider Trading Filed: 2026-04-22

Key Insights

Director Wilbur Maria Cristina Alapag received a restricted stock unit award of 2,976 shares on 04/21/2026 under the Amrize Ltd 2025 Omnibus Incentive Plan, vesting within one year or at the next annual shareholder meeting, indicating continued executive compensation through equity incentives.
Simultaneous sale of 190 ordinary shares at $57.12 per share on the same date suggests a partial liquidity event or rebalancing of holdings, though the sale is minimal relative to the 2,976 share award received.
Post-transaction beneficial ownership stands at 5,934 ordinary shares held directly, showing the director maintains a meaningful stake in the company despite the modest share disposition.

Insider Trading Filed: 2026-04-22

Key Insights

Director Sanche Jacques Wolf acquired 2,976 restricted stock units (RSUs) on 04/21/2026 as part of the 2025 Omnibus Incentive Plan, vesting within one year or at the next shareholder meeting, indicating standard director compensation practices.
Wolf's total beneficial ownership increased to 5,616 ordinary shares (5,576 direct and 40 indirect through a child), demonstrating modest insider confidence but no significant accumulation of company stock.
The transaction involved no cash consideration ($0 price), confirming this is a restricted stock award rather than a market purchase, which limits conclusions about insider conviction regarding stock valuation.
Filing was executed by attorney-in-fact Hans Weinburger rather than the director personally, a procedural note that suggests the transaction was administrative in nature.

Insider Trading Filed: 2026-04-22

Key Insights

Director Robert S. Rivkin received 2,976 restricted stock units (RSUs) as compensation under the 2025 Omnibus Incentive Plan, vesting within one year or at the next annual shareholder meeting, indicating ongoing equity-based incentive structure for leadership.
Rivkin sold 740 ordinary shares at $57.12 per share on 04/21/2026, reducing his direct holdings from 2,958 to 2,218 shares, which represents a modest insider sale likely for liquidity purposes rather than a loss of confidence signal.
Following the RSU vesting and share sale, Rivkin's total beneficial ownership stands at 5,194 ordinary shares, demonstrating continued material stake in the company despite the recent sale transaction.

Insider Trading Filed: 2026-04-22

Key Insights

Director Katja Nicole Roth Pellanda sold 190 ordinary shares at $57.12 per share on 04/21/2026, representing a minor reduction in holdings but suggests confidence in current valuation.
Concurrent with the sale, the reporting person received 2,976 restricted stock units (RSUs) as compensation under the 2025 Omnibus Incentive Plan, vesting within one year, indicating ongoing equity-based incentive participation.
Following the transactions, beneficial ownership increased to 5,744 ordinary shares, demonstrating net positive accumulation despite the modest share sale, reflecting director's continued investment in the company.

Insider Trading Filed: 2026-04-22

Key Insights

Director Oleas Jurg Amadeo acquired 2,976 restricted stock units (RSUs) on 04/21/2026 as part of the Amrize Ltd 2025 Omnibus Incentive Plan, with vesting on the earlier of one-year anniversary or next annual shareholder meeting.
Simultaneous forced sale of 157 ordinary shares at $57.12 per share to cover tax withholding obligations on the RSU vesting, a routine administrative transaction common with equity compensation.
Total beneficial ownership increased to 23,892 ordinary shares following the transaction, indicating the director maintains a meaningful stake in the company after the net acquisition.

Insider Trading Filed: 2026-04-22

Key Insights

Director Nicholas Gangestad executed a significant equity transaction on 04/21/2026, selling 740 ordinary shares at $57.12 per share while simultaneously acquiring 2,976 restricted stock units (RSUs), indicating confidence in long-term company value despite near-term share disposition.
The RSU award vesting is tied to either the one-year anniversary or next annual shareholder meeting, aligning insider incentives with long-term performance and shareholder interests through the 2025 Omnibus Incentive Plan.
Post-transaction beneficial ownership increased to 7,194 ordinary shares directly held, suggesting net accumulation of equity despite the sale, which is a moderately positive signal for insider commitment to the company's future.

Insider Trading Filed: 2026-04-22

Key Insights

Director Donald P. Newman acquired 2,976 restricted stock units (RSUs) on 04/21/2026 as compensation under the 2025 Omnibus Incentive Plan, vesting in one year or at the next annual shareholder meeting.
The RSUs were granted at $0 price, indicating this is a compensation award rather than an open-market purchase, representing routine equity incentive distribution to board leadership.
Newman's modest RSU grant size (2,976 shares) and direct ownership structure suggest limited insider confidence signal compared to larger discretionary purchases, though the transaction itself is procedurally standard for director compensation.

Insider Trading Filed: 2026-04-22

Key Insights

Director Michael E McKelvy received 2,976 restricted stock units (RSUs) on 04/21/2026 as part of the 2025 Omnibus Incentive Plan, vesting in one year or at the next annual shareholder meeting, indicating company confidence in long-term value creation.
McKelvy sold 740 ordinary shares at $57.12 per share on the same date while receiving RSU grants, netting approximately $42,269 in proceeds while maintaining substantial beneficial ownership of 5,194 shares, suggesting selective portfolio rebalancing rather than loss of confidence.
The director's total beneficial ownership increased from 2,218 to 5,194 shares (133% increase) following the RSU award, demonstrating significant alignment between management and shareholder interests despite the concurrent share disposition.

Insider Trading Filed: 2026-04-22

Key Insights

Director Ladhani Holli C. received 2,976 restricted stock units (RSUs) as compensation under the 2025 Omnibus Incentive Plan, vesting within one year or at the next annual shareholder meeting, indicating ongoing equity-based incentive alignment.
Simultaneous sale of 740 ordinary shares at $57.12 per share (likely tax withholding for RSU vesting) while retaining 5,194 total shares demonstrates confidence in the company despite the transaction necessity.
The filing shows insider ownership concentration with the director holding 5,194 shares post-transaction, suggesting meaningful personal investment stake in company performance.

Current Report Filed: 2026-04-21

Key Insights

Strong shareholder approval across all major proposals, with Proposal 1 (Annual Report) receiving 99.8% support, indicating confidence in management's fiscal 2025 performance and financial statements.
Shareholders overwhelmingly approved $0.44 per share special dividend and up to $0.44 per share ordinary dividend in installments, suggesting the company has substantial capital available for shareholder returns.
Board composition changes include Don P. Newman replacing Robert S. Rivkin as Audit Committee chair and Jacques Wolf Sanche joining the Audit Committee, indicating potential governance enhancements in financial oversight.
Jan Jenisch faced notable opposition for Chairman re-election with 47.6 million votes against (17.1% dissent) compared to minimal opposition for other board members, potentially signaling shareholder concerns about his leadership or compensation.
The filing references Swiss statutory compliance (Remuneration Report, capital contribution reserves) alongside U.S. SEC requirements, reflecting the company's dual jurisdiction as a Switzerland-incorporated entity trading on NYSE.

Current Report Filed: 2026-04-14

Key Insights

Amrize Ltd plans to pay a special one-time dividend of $0.44 per share to shareholders if approved at the 2026 Annual General Meeting. This demonstrates the company's strong financial position and willingness to return capital to shareholders.
The ex-dividend date for the special distribution is expected to be April 24, 2026, and the record date for shareholders on the NYSE and SIX Swiss Exchange will be April 24 and April 27, 2026, respectively.
The special distribution is a positive signal for investors, as it indicates the company's confidence in its future cash flow and ability to reward shareholders.

Current Report Filed: 2026-03-31

Key Insights

Amrize Ltd appointed a new Chief Financial Officer, Baris Oran, effective April 1, 2026, replacing the departing Ian Johnston who will serve as a senior advisor during the transition period.
The company entered into an employment agreement with Baris Oran, providing him with a competitive compensation package including an annual base salary of $750,000, annual bonus opportunity of up to 200% of salary, and long-term equity grants with a minimum target value of at least 325% of his base salary.
The CFO transition appears to be orderly, with the departing executive staying on in an advisory role to facilitate a smooth handover, and there are no indications of any disagreements or issues related to the company's financial controls, reporting, or practices.

Insider Trading Filed: 2026-03-23

Key Insights

James J. Gosa, the President of the Building Envelope division, has sold a portion of his Amrize Ltd (AMRZ) shares, disposing of 14,541 ordinary shares on March 21, 2026.
Gosa's remaining beneficial ownership stands at 41,268 shares, including 170 shares acquired through the company's 2025 Employee Stock Purchase Plan.
The transaction suggests Gosa may be realizing some of his equity-based compensation, though his continued ownership of over 41,000 shares indicates he remains invested in the company.

Insider Trading Filed: 2026-03-16

Key Insights

Mario Gross, the Chief Supply Chain Officer of Amrize Ltd, has purchased 3,200 shares of the company's ordinary stock in two separate transactions on March 13, 2026, totaling around $177,500 in value.
The purchases were made at prices of $55.39 and $55.13 per share, indicating that Gross believes the stock is undervalued and has confidence in the company's future performance.
Insider buying, particularly by a senior executive, is often viewed as a positive signal by investors, as it suggests the insider has a favorable outlook on the company's prospects.

Insider Trading Filed: 2026-03-16

Key Insights

The reporting person, Roald Brouwer, who is the Chief Technology Officer of Amrize Ltd, acquired 2,000 ordinary shares of the company on March 13, 2026 at a price of $54.88 per share.
This insider purchase indicates that the reporting person is confident in the company's future prospects and is willing to invest their own capital in the stock.
The reporting person's total beneficial ownership of Amrize Ltd's ordinary shares has increased to 18,257 shares as a result of this transaction.

Insider Trading Filed: 2026-03-11

Key Insights

Insider Ian A. Johnston, the Chief Financial Officer, purchased 4,250 ordinary shares of Amrize Ltd (AMRZ) on March 10, 2026, increasing his direct beneficial ownership to 25,110 shares.
The purchase was made at a price of $58.935 per share, indicating Johnston's confidence in the company's prospects.
Insider buying can be a positive signal to investors, as it suggests the CFO believes the stock is undervalued and has potential for future growth.

Insider Trading Filed: 2026-03-11

Key Insights

The reporting person, Jaime Hill, who is the President of the Building Materials division, acquired 1,000 ordinary shares of Amrize Ltd (AMRZ) at $58.91 per share on March 11, 2026.
This transaction increases Hill's direct beneficial ownership in the company to 27,000 ordinary shares.
Insider buying can be a positive signal that the reporting person is confident in the company's future performance.

Insider Trading Filed: 2026-03-11

Key Insights

Roald Brouwer, the Chief Technology Officer of Amrize Ltd, purchased 3,000 ordinary shares of the company on March 11, 2026 at a price of $58.72 per share, increasing his direct ownership to 16,257 shares.
The transaction represents a notable insider purchase, suggesting Brouwer's confidence in the company's prospects.
Investors should monitor any future insider buying or selling activity, as it may provide insights into management's views on the company's valuation and performance.

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Key Insights

Important Information